Luis Gerardo Rodriguez

Grupo de investigación

Mieloma, amiloidosis, macroglobulinemia y otras gammapatías Accredited researcher (R3A)

lgrodriguez@clinic.cat 0000-0001-5694-0921

Síguelo/a en:

El perfil Researchgate de Luis Gerardo . Este enlace se abre en una nueva pestaña.

Publicaciones destacadas

Complement as the enabler of carfilzomib-induced thrombotic microangiopathy

Autores:
Blasco, M; Martínez-Roca, A; Rodríguez-Lobato, LG; Garcia-Herrera, A; Rosiñol, L;

(...)

Guillen, E; Campistol, JM; Carreras, E; Diaz-Ricart, M; Palomo, M.

Referencia: British Journal Of Haematology 2021.
Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma

Autores:
Lozano E; Mena MP; Díaz T; Martin-Antonio B; León S;

(...)

Cibeira MT; Bladé J; Prat A; Rosiñol L; Fernández de Larrea C .

Referencia: Clinical Cancer Research 2020.
CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions

Autores:
Rodríguez-Lobato LG; Ganzetti M; Fernández de Larrea C; Hudecek M; Einsele H;

Danhof S .

Referencia: Frontiers In Oncology 2020.
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis

Autores:
Gutierrez-Garcia, Gonzalo; Villarreal, Jesus; Garrote, Marta; Rovira, Montserrat; Blasco, Miquel;

(...)

Carreras, Enric; Urbano-Ispizua, Alvaro; Fernandez-Aviles, Francesc; Pereira, A; Quintana, Luis F.

Referencia: Bone Marrow Transplantation 2020.
Impact of intensifying primary antibiotic prophylaxis in at-home autologous stem cell transplantation program for lymphoma patients

Autores:
Rodriguez-Lobato, Luis Gerardo; Martinez-Roca, Alexandra; Moreno, David F; Gutierrez-Garcia, Gonzalo; Suarez-Lledo, Maria;

(...)

Gallego, Cristina; Hernando, Adelina; Segura, Susana; Urbano-Ispizua, Alvaro; Fernandez-Aviles, Francesc.

Referencia: Leukemia & Lymphoma 2020.
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe

Autores:
Gutierrez-Garcia, Gonzalo; Rovira, Montserrat; Arab, Nacira; Gallego, Cristina; Sanchez, Joan;

(...)

Cid, Joan; Martinez, Carmen; Suarez-Lledo, Maria; Urbano-Ispizua, Alvaro; Fernandez-Aviles, Francesc.

Referencia: Bone Marrow Transplantation 2020.
Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.

Autores:
Gonzalo Gutiérrez García; María Teresa Cibeira; Montserrat Rovira; Carlos Fernández de Larrea; Natalia Tovar;

(...)

Álvaro Urbano Ispizua; Jordi Esteve; Enric Carreras; Francesc Fernández Avilés; Joan Bladé.

Referencia: Bone Marrow Transplantation 2019.
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.

Autores:
Lozano, Ester; Diaz, Tania; Mena, Mari-Pau; Sune, Guillermo; Calvo, Xavier;

(...)

Isola, Ignacio; Rodriguez-Lobato, Luis-Gerardo; Martin-Antonio, Beatriz; Blade, Joan; Fernandez De larrea, Carlos.

Referencia: Journal Of Immunology 2018.
Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome.

Autores:
Tovar N; Rodríguez-Lobato LG; Cibeira MT; Magnano L; Isola I;

Rosiñol L; Bladé J; Fernández de Larrea C .

Referencia: Amyloid-Journal Of Protein Folding Disorders 2018.
Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis

Autores:
Rodríguez-Lobato L; Fernández de Larrea C; Cibeira M; Tovar N; Isola I;

(...)

Rosiñol L; Díaz T; Lozano E; Yagüe J; Bladé J.

Referencia: Amyloid-Journal Of Protein Folding Disorders 2017.

Proyectos destacados

Ensayo clínico fase II sobre el uso de un CART humanizado dirigido contra BCMA (ARI0002h) en pacientes con mieloma múltiple recaído/refractario a inhibidores del proteasoma, inmunomoduladores y anticuerpos anti-CD38

Financiador: Clínica Universitaria de Navarra; Complejo Hospitalario de Salamanca; Hospital Clínic de Barcelona; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Participante)

Duración: 01/01/2019
Biomedicine international training research programme for excellent clinician-scientists "BITRECS"

Investigador/a principal: Luis Gerardo Rodríguez Lobato

Financiador: Institut d'investigació Biomèdiques August Pi i Sunyer (Sede o evento); La Caixa Foundation; Comisión Europea ; Institut d`Investigacions Biomèdiques August Pi i Sunyer (Participante); Biomedicine international training research programme for excellent clinician-scientists (BITRECS) (Programa financiador competitivo)

Duración: 01/09/2019 - 01/08/2022
Improving CAR T cell immunotherapy through immune checkpoint inhibition to achieve a sustained response in patients with multiple myeloma.

Investigador/a principal: David Fernando Moreno Fajardo

Financiador: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede o evento)

Duración: 01/01/2019 - 01/01/2020

Luis Gerardo Rodriguez

Grupo de investigación

Publicaciones destacadas

Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.

Proyectos destacados

Ensayo clínico fase II sobre el uso de un CART humanizado dirigido contra BCMA (ARI0002h) en pacientes con mieloma múltiple recaído/refractario a inhibidores del proteasoma, inmunomoduladores y anticuerpos anti-CD38

Biomedicine international training research programme for excellent clinician-scientists "BITRECS"

Improving CAR T cell immunotherapy through immune checkpoint inhibition to achieve a sustained response in patients with multiple myeloma.

Suscríbete a la Newsletter del Clínic